Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.228 USD | +4.14% | +1.05% | -57.80% |
Mar. 26 | GT Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 01 | GT Biopharma to Conduct 1-for-30 Reverse Stock Split; Shares Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.80% | 4.28M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- GTBP Stock
- News GT Biopharma, Inc.
- HC Wainwright Adjusts Price Target on GT Biopharma to $5 From $25, Reiterates Buy Rating